April 10, 2024 10:48 AM EDT
News Briefing

Skye Bio­science up­lists; On­coX's li­cens­ing deal with AB­VC Bio­Phar­ma

ENDPOINTS

Plus, news about Zevra Ther­a­peu­tics and YS Bio­phar­ma:

Skye Bio­science up­lists to the Nas­daq: The San Diego biotech $SKYE is set to make the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Will CRISPR mat­ter?

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times